Bispecific Antibody Development Programs Guidance for Industry
Detailed guidance document from FDA and regulatory agencies.
Document Details
Guidance Document
May 24, 2021
May 24, 2021
16d40dbb-63de-4441-b656-7949b4a1018d
Related Documents
M9 Biopharmaceutics Classification System-Based Biowaivers
Guidance DocumentMay 11, 2021Center for Drug Evaluation and Research
Field Alert Report Submission: Questions and Answers Guidance for Industry: Guidance for Industry
Guidance DocumentJuly 22, 2021Center for Drug Evaluation and Research
Elemental Impurities in Drug Products Guidance for Industry
Guidance DocumentAugust 8, 2018Center for Drug Evaluation and Research
Quick Actions
Transform Regulatory Data into Actionable Intelligence
Join leading pharmaceutical and medical device companies who trust GKS for their regulatory compliance needs.
Try KeyPedia Today
Explore our real use cases and discover our features in depth.
Stay ahead of FDA enforcement
New KeyPedia insights, webinars, and regulatory analysis — straight to your inbox. Unsubscribe anytime.